A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008
Clinical trial NCT04946903 · COMPLETED
Trial details
- NCT number
- NCT04946903
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-10
- Primary completion
- 2021-08-10
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.